{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T11:11:36Z","timestamp":1774264296484,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.ahj.2012.08.015","type":"journal-article","created":{"date-parts":[[2012,11,6]],"date-time":"2012-11-06T04:52:11Z","timestamp":1352177531000},"page":"793-799.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Quality of life and chronic heart failure therapy guided by natriuretic peptides: Results from the ProBNP Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) study"],"prefix":"10.1016","volume":"164","clinical-trial-number":[{"clinical-trial-number":"nct00351390","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Anju","family":"Bhardwaj","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shafiq U.","family":"Rehman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asim A.","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanna K.","family":"Gaggin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Barajas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justine","family":"Barajas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie A.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorothy","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James L.","family":"Januzzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2012.08.015_bb0005","first-page":"e46","article-title":"Heart disease and stroke statistics\u20132010 update: a report from the American Heart Association","volume":"121","author":"Lloyd-Jones","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2012.08.015_bb0010","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1161\/CIRCULATIONAHA.104.492033","article-title":"Changing incidence and survival for heart failure in a well-defined older population, 1970-1974 and 1990-1994","volume":"113","author":"Barker","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2012.08.015_bb0015","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1053\/euhj.2002.3255","article-title":"Impact of heart failure and left ventricular systolic dysfunction on quality of life","volume":"23","author":"Hobbs","year":"2002","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2012.08.015_bb0020","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/S1053-2498(01)00298-4","article-title":"Preferences for quality of life or survival expressed by patients with heart failure","volume":"20","author":"Lewis","year":"2001","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.ahj.2012.08.015_bb0025","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1054\/jcaf.2000.9503","article-title":"Preferences for treatment outcomes in patients with heart failure: symptoms versus survival","volume":"6","author":"Stanek","year":"2000","journal-title":"J Card Fail"},{"key":"10.1016\/j.ahj.2012.08.015_bb0030","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1161\/01.CIR.101.12.e122","article-title":"Evaluating quality of care for patients with heart failure","volume":"101","author":"Krumholz","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2012.08.015_bb0035","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2008.11.013","volume":"53","author":"Hunt","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2012.08.015_bb0040","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.cardfail.2004.11.004","article-title":"Effect of Valsartan on quality of life when added to usual therapy for heart failure: results from the Valsartan Heart Failure Trial","volume":"11","author":"Majani","year":"2005","journal-title":"J Card Fail"},{"key":"10.1016\/j.ahj.2012.08.015_bb0045","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/0735-1097(94)90426-X","article-title":"Quality of life among 5,025 patients with left ventricular dysfunction randomized between placebo and enalapril: the studies of left ventricular dysfunction. The SOLVD investigators","volume":"23","author":"Rogers","year":"1994","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2012.08.015_bb0050","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1001\/jama.283.10.1295","article-title":"Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure. The metoprolol CR\/XL randomized intervention trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group","volume":"283","author":"Hjalmarson","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2012.08.015_bb0055","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1161\/01.CIR.98.12.1184","article-title":"Clinical effects of beta adrenergic blockade in chronic heart failure. A Meta-analysis of double-blind, placebo-controlled, randomized trials","volume":"98","author":"Lechat","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2012.08.015_bb0060","doi-asserted-by":"crossref","first-page":"550","DOI":"10.7326\/0003-4819-134-7-200104030-00008","article-title":"beta Blockers in congestive heart failure. A Bayesian meta-analysis","volume":"134","author":"Brophy","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ahj.2012.08.015_bb0065","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.cardfail.2009.05.003","article-title":"Improvement in health-related quality of life after hospitalization predicts event-free survival in patients with advanced heart failure","volume":"15","author":"Moser","year":"2009","journal-title":"J Cardiac Fail"},{"key":"10.1016\/j.ahj.2012.08.015_bb0070","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.clinbiochem.2010.09.007","article-title":"Post-discharge changes in NT-proBNP and quality of life after acute dyspnea hospitalization as predictors of one-year outcomes","volume":"43","author":"Shah","year":"2010","journal-title":"Clin Biochem"},{"key":"10.1016\/j.ahj.2012.08.015_bb0075","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.amjcard.2004.12.032","article-title":"The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study","volume":"95","author":"Januzzi","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2012.08.015_bb0080","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.jacc.2008.04.069","article-title":"Prognostic value of changes in N-terminal pro-brain natriuretic peptide in Val-HeFT (Valsartan Heart Failure Trial)","volume":"52","author":"Masson","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2012.08.015_bb0085","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/j.jacc.2011.03.072","article-title":"Use of amino-terminal pro-B type natriuretic peptide to guide outpatient therapy of patients with chronic left ventricular systolic dysfunction","volume":"58","author":"Januzzi","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2012.08.015_bb0090","first-page":"198","article-title":"Patient's self-assessment of their congestive heart failure: content, reliability and validity of a new measure, The Minnesota Living with Heart Failure Questionnaire","volume":"3","author":"Rector","year":"1987","journal-title":"Heart Fail"},{"key":"10.1016\/j.ahj.2012.08.015_bb0095","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.ahj.2010.01.005","article-title":"Design and methods of the Pro-B type Natriuretic Peptide Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) study","volume":"159","author":"Bhardwaj","year":"2010","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2012.08.015_bb0100","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1373\/clinchem.2006.069575","article-title":"Direct comparison of B-type natriuretic peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: the Valsartan Heart Failure (Val-HeFT) data","volume":"52","author":"Masson","year":"2006","journal-title":"Clin Chem"},{"key":"10.1016\/j.ahj.2012.08.015_bb0105","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1016\/j.jacc.2009.06.041","volume":"54","author":"Cleland","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2012.08.015_bb0110","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/HJR.0b013e32828622c3","article-title":"Quality of life assessment in heart failure interventions: a 10-year (1996-2005) review","volume":"14","author":"Morgan","year":"2007","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"10.1016\/j.ahj.2012.08.015_bb0115","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.cardfail.2005.02.004","article-title":"The relationship between B-type natriuretic peptide and health status in patients with heart failure","volume":"11","author":"Luther","year":"2005","journal-title":"J Card Fail"},{"key":"10.1016\/j.ahj.2012.08.015_bb0120","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1001\/jama.2009.2","article-title":"BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial","volume":"301","author":"Pfisterer","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2012.08.015_bb0125","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/S0140-6736(00)02060-2","article-title":"Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations","volume":"355","author":"Troughton","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2012.08.015_bb0130","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jacc.2009.02.095","article-title":"N-terminal pro-B-type natriuretic peptide-guided treatment for chronic heart failure: results from the BATTLESCARRED (NT-proBNP-Assisted Treatment To Lessen Serial Cardiac Readmissions and Death) trial","volume":"55","author":"Lainchbury","year":"2009","journal-title":"J Am Coll Cardiol"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870312005947?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870312005947?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:48:20Z","timestamp":1757569700000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870312005947"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S0002870312005947"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2012.08.015","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quality of life and chronic heart failure therapy guided by natriuretic peptides: Results from the ProBNP Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) study","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2012.08.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}